LeonaBio to Participate in Cantor Global Healthcare Conference 2026
LeonaBio plans a webcast fireside chat at the 2026 Cantor Global Healthcare Conference, with live access and a 30-day replay for investors.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
LeonaBio (LONA)/b) will participate in the Cantor Global Healthcare Conference 2026 in New York from September 9–11, 2026.Company management will join a fireside chat on Friday, September 11, 2026, from 9:45 am to 10:15 am EDT. A live webcast and at least 30-day replay will be available via the Investors section of LeonaBio’s website.
Details
News Market Reaction – LONA
On Sep 3, the day this news came out, LONA closed 0.39% above the previous close. Our momentum scanner recorded 2 alerts in the available session data.
Data tracked by StockTitan Argus for the Sep 3 session.
Key Figures
- Conference dates
- September 9-11, 2026
- Cantor Global Healthcare Conference 2026
- Fireside chat time
- 9:45 am-10:15 am EDT
- Friday, September 11, 2026
- Replay availability
- At least 30 days
- Following the event
Historical Context
-
Higher expenses, net loss, and reduced cash accompanied Phase 3 enrollment progress.
-
Lasofoxifene presentations and planned Phase 3 enrollment completion were highlighted.
-
Brelgometon development plans and Phase 1 support were presented at an ALS summit.
-
The company announced presentations at ALS and BIO industry meetings.
-
Financing resources and pipeline updates accompanied first-quarter financial results.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOTHELL, Wash., Sept. 03, 2026 (GLOBE NEWSWIRE) -- LeonaBio, Inc. (NASDAQ: LONA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, today announced that Company management will participate in the Cantor Global Healthcare Conference 2026, taking place September 9-11, 2026 in New York, NY. Details are as follows:
Cantor Global Healthcare Conference 2026
Format: Fireside Chat
Date and Time: Friday, September 11, 2026, from 9:45 am – 10:15 am EDT
Location: New York, NY
A live webcast of the fireside chat can be accessed from the Investors section of the LeonaBio website at https://investors.leonabio.com/news-and-events/events-and-presentations-investor. An archived replay will be available for at least 30 days following the event.
About LeonaBio
LeonaBio, headquartered in the Seattle, Washington area, is a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS), with the goal of improving patients’ lives. Our lead drug candidates, lasofoxifene and brelgometon (ATH-1105), are novel, small molecule therapies with the potential to address devastating diseases where current treatment options are limited or ineffective. With a strong commitment to scientific excellence and patient-centered innovation, we are dedicated to developing meaningful new therapies for those who need them most.
For more information, visit www.leonabio.com.
Investor & Media Contact:
Julie Rathbun
LeonaBio
Julie.rathbun@leonabio.com
206-769-9219
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.